Natural killer NKG2A and NKG2D in patients with colorectal cancer | Zendy

Ghada Refaat Meckawy | Zendy; Ahmed Mostafa Mohamed | Zendy; Wafaa K. Zaki | Zendy; Mona A. Khattab | Zendy; Mariam Maged Amin | Zendy; Mai Eldeeb | Zendy; Marwa Rushdy | Zendy; Nesma Ahmed Safwat | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Natural killer NKG2A and NKG2D in patients with colorectal cancer

Author(s) -

Ghada Refaat Meckawy,

Ahmed Mostafa Mohamed,

Wafaa K. Zaki,

Mona A. Khattab,

Mariam Maged Amin,

Mai Eldeeb,

Marwa Rushdy,

Nesma Ahmed Safwat

Publication year - 2019

Publication title -

journal of gastrointestinal oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.084

H-Index - 39

eISSN - 2219-679X

pISSN - 2078-6891

DOI - 10.21037/jgo.2018.12.13

Subject(s) - nkg2d , medicine , colorectal cancer , peripheral blood mononuclear cell , immune system , natural killer cell , immunology , gastroenterology , cancer , cytotoxic t cell , oncology , in vitro , biology , biochemistry

Natural-killer group 2 (NKG2), a characteristic receptor of natural killer (NK) cell family, assumes a vital role in modulating NK cytotoxic function. We aimed to detect mRNA expression of both NKG2A and NKG2D in serum NK cells obtained from colorectal cancer (CRC) patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research